{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T22:58:58Z","timestamp":1784761138502,"version":"3.55.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","cancerletters.info","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.canlet.2017.09.002","type":"journal-article","created":{"date-parts":[[2017,9,19]],"date-time":"2017-09-19T03:02:27Z","timestamp":1505790147000},"page":"228-237","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"special_numbering":"C","title":["Smac mimetics and type II interferon synergistically induce necroptosis in various cancer cell lines"],"prefix":"10.1016","volume":"410","author":[{"given":"Michael John","family":"Cekay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanie","family":"Roesler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanja","family":"Frank","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Kathrin","family":"Knuth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ines","family":"Eckhardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0459-6417","authenticated-orcid":false,"given":"Simone","family":"Fulda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2017.09.002_bib1","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2017.09.002_bib2","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1002\/ijc.24064","article-title":"Tumor resistance to apoptosis","volume":"124","author":"Fulda","year":"2009","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.canlet.2017.09.002_bib3","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/nrm3737","article-title":"Regulated necrosis: the expanding network of non-apoptotic cell death pathways","volume":"15","author":"Vanden Berghe","year":"2014","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.canlet.2017.09.002_bib4","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1038\/nrm2970","article-title":"Molecular mechanisms of necroptosis: an ordered cellular explosion","volume":"11","author":"Vandenabeele","year":"2010","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.canlet.2017.09.002_bib5","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.celrep.2014.04.026","article-title":"MLKL compromises plasma membrane integrity by binding to phosphatidylinositol phosphates","volume":"7","author":"Dondelinger","year":"2014","journal-title":"Cell Rep."},{"key":"10.1016\/j.canlet.2017.09.002_bib6","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.molcel.2014.03.003","article-title":"Mixed lineage kinase domain-like protein MLKL causes necrotic membrane disruption upon phosphorylation by RIP3","volume":"54","author":"Wang","year":"2014","journal-title":"Mol. Cell"},{"key":"10.1016\/j.canlet.2017.09.002_bib7","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/nature09852","article-title":"Catalytic activity of the caspase-8-FLIP(L) complex inhibits RIPK3-dependent necrosis","volume":"471","author":"Oberst","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2017.09.002_bib8","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.canlet.2016.05.036","article-title":"Smac mimetic triggers necroptosis in pancreatic carcinoma cells when caspase activation is blocked","volume":"380","author":"Hannes","year":"2016","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2017.09.002_bib9","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1593\/neo.11610","article-title":"Smac mimetic bypasses apoptosis resistance in FADD- or caspase-8-deficient cells by priming for tumor necrosis factor alpha-induced necroptosis","volume":"13","author":"Laukens","year":"2011","journal-title":"Neoplasia"},{"key":"10.1016\/j.canlet.2017.09.002_bib10","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1038\/onc.2016.310","article-title":"Therapeutic targeting of necroptosis by Smac mimetic bypasses apoptosis resistance in acute myeloid leukemia cells","volume":"36","author":"Safferthal","year":"2017","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2017.09.002_bib11","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/nrd3627","article-title":"Targeting IAP proteins for therapeutic intervention in cancer","volume":"11","author":"Fulda","year":"2012","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.canlet.2017.09.002_bib12","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.cell.2007.10.030","article-title":"IAP antagonists induce autoubiquitination of c-IAPs, NF-kappaB activation, and TNFalpha-dependent apoptosis","volume":"131","author":"Varfolomeev","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2017.09.002_bib13","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.cell.2007.10.037","article-title":"IAP antagonists target cIAP1 to induce TNFalpha-dependent apoptosis","volume":"131","author":"Vince","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2017.09.002_bib14","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.ccr.2007.08.029","article-title":"Autocrine TNFalpha signaling renders human cancer cells susceptible to Smac-mimetic-induced apoptosis","volume":"12","author":"Petersen","year":"2007","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2017.09.002_bib15","doi-asserted-by":"crossref","first-page":"3709","DOI":"10.18632\/oncotarget.6915","article-title":"Cooperative TRAIL production mediates IFNalpha\/Smac mimetic-induced cell death in TNFalpha-resistant solid cancer cells","volume":"7","author":"Roesler","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2017.09.002_bib16","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.canlet.2014.08.040","article-title":"Synergistic interaction of Smac mimetic and IFNalpha to trigger apoptosis in acute myeloid leukemia cells","volume":"355","author":"Bake","year":"2014","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2017.09.002_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2016.02.019","article-title":"Smac mimetic sensitizes renal cell carcinoma cells to interferon-alpha-induced apoptosis","volume":"375","author":"Reiter","year":"2016","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2017.09.002_bib18","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/nrc.2016.14","article-title":"Antitumour actions of interferons: implications for cancer therapy","volume":"16","author":"Parker","year":"2016","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.canlet.2017.09.002_bib19","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2013.457","article-title":"Identification of DR5 as a critical, NF-kappaB-regulated mediator of Smac-induced apoptosis","volume":"4","author":"Eckhardt","year":"2013","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.canlet.2017.09.002_bib20","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1182\/blood.V95.1.301","article-title":"Functional CD95 ligand and CD95 death-inducing signaling complex in activation-induced cell death and doxorubicin-induced apoptosis in leukemic T cells","volume":"95","author":"Fulda","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2017.09.002_bib21","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1158\/0008-5472.CAN-09-1947","article-title":"Drug combination studies and their synergy quantification using the Chou-Talalay method","volume":"70","author":"Chou","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2017.09.002_bib22","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1146\/annurev.immunol.26.021607.090400","article-title":"The IRF family transcription factors in immunity and oncogenesis","volume":"26","author":"Tamura","year":"2008","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.canlet.2017.09.002_bib23","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.semcdb.2014.07.002","article-title":"Therapeutic exploitation of necroptosis for cancer therapy","volume":"35","author":"Fulda","year":"2014","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.canlet.2017.09.002_bib24","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1182\/blood-2013-05-500918","article-title":"Smac mimetic and glucocorticoids synergize to induce apoptosis in childhood ALL by promoting ripoptosome assembly","volume":"124","author":"Belz","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2017.09.002_bib25","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms14278","article-title":"Smac mimetics synergize with immune checkpoint inhibitors to promote tumour immunity against glioblastoma","volume":"8","author":"Beug","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2017.09.002_bib26","doi-asserted-by":"crossref","first-page":"5030","DOI":"10.1158\/1078-0432.CCR-15-0365","article-title":"Promises and challenges of Smac mimetics as cancer therapeutics","volume":"21","author":"Fulda","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2017.09.002_bib27","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jbiotec.2016.10.022","article-title":"Review of the recombinant human interferon gamma as an immunotherapeutic: impacts of production platforms and glycosylation","volume":"240","author":"Razaghi","year":"2016","journal-title":"J.\u00a0Biotechnol."},{"key":"10.1016\/j.canlet.2017.09.002_bib28","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2014.498","article-title":"Identification of IRF1 as critical dual regulator of Smac mimetic-induced apoptosis and inflammatory cytokine response","volume":"5","author":"Eckhardt","year":"2014","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.canlet.2017.09.002_bib29","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ejca.2016.12.028","article-title":"Rationale for stimulator of interferon genes-targeted cancer immunotherapy","volume":"75","author":"Rivera Vargas","year":"2017","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.canlet.2017.09.002_bib30","doi-asserted-by":"crossref","first-page":"4730","DOI":"10.18632\/oncotarget.13972","article-title":"Oncolytic adenovirus coexpressing interleukin-12 and decorin overcomes Treg-mediated immunosuppression inducing potent antitumor effects in a weakly immunogenic tumor model","volume":"8","author":"Oh","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2017.09.002_bib31","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/cdd.2016.102","article-title":"A\u00a0Bak-dependent mitochondrial amplification step contributes to Smac mimetic\/glucocorticoid-induced necroptosis","volume":"24","author":"Rohde","year":"2017","journal-title":"Cell Death Differ."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383517305499?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383517305499?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,17]],"date-time":"2020-10-17T21:42:09Z","timestamp":1602970929000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383517305499"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":31,"alternative-id":["S0304383517305499"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2017.09.002","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Smac mimetics and type II interferon synergistically induce necroptosis in various cancer cell lines","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2017.09.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}